The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the Familial Risk–Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guidelines
Open accessAbstract
Purpose: To provide recommendations on prevention, screening, genetics, treatment, and management for people at risk for hereditary colorectal cancer (CRC) syndromes. The American Society of Clinical Oncology (ASCO) has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. Methods: The Familial Risk–Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guideline published in 2013 on behalf of the European Society for Medical Oncology (ESMO) Guidelines Working Group in Annals of Oncology was reviewed for developmental rigor by methodologists, with content and recommendations reviewed by an ASCO endorsement panel. Results: The ASCO endorsement panel determined that the recommendations of the ESMO guidelines are clear, thorough, and based on the most relevant scientific evidence. The ASCO panel endorsed the ESMO guidelines and added a few qualifying statements. Recommendations: Approximately 5% to 6% of patient cases of CRC are associated with germline mutations that confer an inherited predisposition for cancer. The possibility of a hereditary cancer syndrome should be assessed for every patient at the time of CRC diagnosis. A diagnosis of Lynch syndrome, familial adenomatous polyposis, or another genetic syndrome can influence clinical management for patients with CRC and their family members. Screening for hereditary cancer syndromes in patients with CRC should include review of personal and family histories and testing of tumors for DNA mismatch repair deficiency and/or microsatellite instability. Formal genetic evaluation is recommended for individuals who meet defined criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Self-citationLynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds236 · Cited by 1,510
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043146 · Cited by 1,408 · cited 1×
“These alterations convey a predisposition to develop tumors with phenotypes of DNA microsatellite instability (MSI),(3) which often demonstrate loss of expression of the corresponding MMR protein detected by immunohistochemistry (IHC) techniques.(4,5) Lifetime cancer risk for carriers of MMR gene mutations is highest…”
BackgroundJärvinen, H. J., Aarnio, M., Mustonen, H., Aktan–Collan, K., Aaltonen, L. A., Peltomäki, P., Chapelle, A. D. L., & Mecklin, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70168-5 · Cited by 1,337
Burn, J., Gerdes, A.-M., Macrae, F., Mecklin, J.-P., Moeslein, G., Olschwang, S., Eccles, D., Evans, D. G., Maher, E. R., Bertario, L., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61049-0 · Cited by 952
Multiple Colorectal Adenomas, Classic Adenomatous Polyposis, and Germ-Line Mutations in MYH
Sieber, O. M., Lipton, L., Crabtree, M., Heinimann, K., Fidalgo, P., Phillips, R. K. S., Bisgaard, M.-L., Orntoft, T. F., Aaltonen, L. A., Hodgson, S. V., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025283 · Cited by 862
Ligtenberg, M. J. L., Kuiper, R. P., Chan, T. L., Goossens, M., Hebeda, K. M., Voorendt, M., Lee, T. Y. H., Bodmer, D., Hoenselaar, E., Hendriks-Cornelissen, S. J. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.283 · Cited by 818
Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome
Schmeler, K. M., Lynch, H. T., Chen, L.-M., Munsell, M. F., Soliman, P. T., Clark, M. B., Daniels, M. S., White, K. G., Boyd-Rogers, S. G., Conrad, P. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052627 · Cited by 794
Self-citationLife‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome
Aarnio, M., Mecklin, J., Aaltonen, L. A., Nyström‐Lahti, M., & Järvinen, H. J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640613 · Cited by 599
Identification of Lynch Syndrome Among Patients With Colorectal Cancer
Moreira, L., Balaguer, F., Lindor, N., de la Chapelle, A., Hampel, H., Aaltonen, L. A., Hopper, J. L., Le Marchand, L., Gallinger, S., Newcomb, P. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.13088 · Cited by 556
The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations
Senter, L., Clendenning, M., Sotamaa, K., Hampel, H., Green, J., Potter, J. D., Lindblom, A., Lagerstedt, K., Thibodeau, S. N., Lindor, N. M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.026 · Cited by 550
Lindor, N. M., Rabe, K., Petersen, G. M., Haile, R., Casey, G., Baron, J., Gallinger, S., Bapat, B., Aronson, M., Hopper, J., et al. (2005) · JAMA · doi:10.1001/jama.293.16.1979 · Cited by 546
Giardiello, F. M., Allen, J. I., Axilbund, J. E., Boland, R. C., Burke, C. A., Burt, R. W., Church, J. M., Dominitz, J. A., Johnson, D. A., Kaltenbach, T., et al. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.186 · Cited by 483
Palomaki, G. E., McClain, M. R., Melillo, S., Hampel, H. L., & Thibodeau, S. N. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e31818fa2db · Cited by 467
Vasen, H. F. A., Stormorken, A., Menko, F. H., Nagengast, F. M., Kleibeuker, J. H., Griffioen, G., Taal, B. G., Moller, P., & Wijnen, J. T. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.20.4074 · Cited by 406
Nieuwenhuis, M. H., & Vasen, H. F. A. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.004 · Cited by 387
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome
Stoffel, E., Mukherjee, B., Raymond, V. M., Tayob, N., Kastrinos, F., Sparr, J., Wang, F., Bandipalliam, P., Syngal, S., & Gruber, S. B. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.039 · Cited by 360
Self-citationWin, A. K., Young, J. P., Lindor, N. M., Tucker, K. M., Ahnen, D. J., Young, G. P., Buchanan, D. D., Clendenning, M., Giles, G. G., Winship, I., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5590 · Cited by 333
Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome
Engel, C., Loeffler, M., Steinke, V., Rahner, N., Holinski-Feder, E., Dietmaier, W., Schackert, H. K., Goergens, H., von Knebel Doeberitz, M., Goecke, T. O., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2278 · Cited by 306
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
Kempers, M. J., Kuiper, R. P., Ockeloen, C. W., Chappuis, P. O., Hutter, P., Rahner, N., Schackert, H. K., Steinke, V., Holinski-Feder, E., Morak, M., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70265-5 · Cited by 295
Self-citationExtra-Intestinal Manifestations of Familial Adenomatous Polyposis
Groen, E. J., Roos, A., Muntinghe, F. L., Enting, R. H., de Vries, J., Kleibeuker, J. H., Witjes, M. J. H., Links, T. P., & van Beek, A. P. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9981-3 · Cited by 261
Prevalence and Phenotypes of APC and MUTYH Mutations in Patients With Multiple Colorectal Adenomas
Grover, S., Kastrinos, F., Steyerberg, E. W., Cook, E. F., Dewanwala, A., Burbidge, L. A., Wenstrup, R. J., & Syngal, S. (2012) · JAMA · doi:10.1001/jama.2012.8780 · Cited by 246
Plaschke, J., Engel, C., Krüger, S., Holinski-Feder, E., Pagenstecher, C., Mangold, E., Moeslein, G., Schulmann, K., Gebert, J., von Knebel Doeberitz, M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.033 · Cited by 245
Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome
Niessen, R. C., Hofstra, R. M. W., Westers, H., Ligtenberg, M. J. L., Kooi, K., Jager, P. O. J., de Groote, M. L., Dijkhuizen, T., Olderode‐Berends, M. J. W., Hollema, H., et al. (2009) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20678 · Cited by 222
Goecke, T. O., Schulmann, K., Engel, C., Holinski‐Feder, E., Pagenstecher, C., Schackert, H. K., Kloor, M., Kunstmann, E., Vogelsang, H., Keller, G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7333 · Cited by 165
Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines
Balmaña, J., Balaguer, F., Cervantes, A., & Arnold, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt209 · Cited by 165
Weissman, S. M., Burt, R. W., Church, J. M., Erdman, S., Hampel, H., Holter, S., Jasperson, K. W., Kalady, M. F., Haidle, J. L., Lynch, H. T., et al. (2011) · Journal of Genetic Counseling · doi:10.1007/s10897-011-9465-7 · Cited by 152
Self-citationBalaguer, F., Castellvı́-Bel, S., Castells, A., Andreu, M. G., Muñoz, J., Gisbert, J. P., Llor, X., Jover, R., de Cid, R., Gonzalo, V., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.025 · Cited by 151
Risks of Colorectal and Other Cancers After Endometrial Cancer for Women With Lynch Syndrome
Win, A. K., Lindor, N. M., Winship, I., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs525 · Cited by 106
Makar, K. W., Poole, E. M., Resler, A. J., Seufert, B. L., Curtin, K., Kleinstein, S. E., Duggan, D. J., Kulmacz, R. J., Hsu, L., Whitton, J. A., et al. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0282-1 · Cited by 51
Munck, À., Gargouri, L., Alberti, C., Viala, J., Peuchmaur, M. M., Lenaerts, C., Michaud, L., Lamireau, T., Mougenot, J. F., Dabadie, A., et al. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3182198f4d · Cited by 26
Pavlidis, N. A., Stahel, R. A., Hansen, H., & Cervantes, A. M. R. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr370 · Cited by 11
Cited by
Luchini, C., Bibeau, F., Ligtenberg, M. J. L., Singh, N., Nottegar, A., Bosse, T., Miller, R., Riaz, N., Douillard, J.-Y., Andre, F., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz116 · Cited by 1,041
Fassnacht, M., Dekkers, O. M., Else, T., Baudin, E., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assie, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 961
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0003 · Cited by 650
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma
Shindo, K., Yu, J., Suenaga, M., Fesharakizadeh, S., Cho, C., Macgregor-Das, A., Siddiqui, A., Witmer, P. D., Tamura, K., Song, T. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.3502 · Cited by 458
Early-onset colorectal cancer: initial clues and current views
Hofseth, L. J., Hebert, J. R., Chanda, A., Chen, H., Love, B. L., Pena, M. M., Murphy, E. A., Sajish, M., Sheth, A., Buckhaults, P. J., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0253-4 · Cited by 428
Metadata
- Authors
- Stoffel, E. M., Mangu, P. B., Gruber, S. B., Hamilton, S. R., Kalady, M. F., Lau, M. W. Y., Lu, K. H., Roach, N., & Limburg, P. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-01-10
- Volume
- 33
- Issue
- 2
- Pages
- 209-217
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2106832044
- Cited by
- 373
- References
- 37
- FWCI
- 22.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.